Loomis, Sayles & Company
MIRM icon

Loomis, Sayles & Company’s Mirum Pharmaceuticals MIRM Stock Holding History

Loomis, Sayles & Company’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$28.1M Sell
552,957
-13,198
-2% -$672K 0.04% 184
2025
Q1 		$25.5M Sell
566,155
-11,869
-2% -$535K 0.04% 202
2024
Q4 		$23.9M Buy
578,024
+78,708
+16% +$3.25M 0.03% 228
2024
Q3 		$19.5M Buy
+499,316
New +$19.5M 0.03% 259